Mangrove Partners’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-108,914
| Closed | -$1.75M | – | 368 |
|
|
2020
Q4 | $1.75M | Sell |
108,914
-304,895
| -74% | -$4.89M | 0.24% | 66 |
|
|
2020
Q3 | $4.42M | Sell |
413,809
-7,280
| -2% | -$77.7K | 0.56% | 35 |
|
|
2020
Q2 | $5.1M | Sell |
421,089
-18,443
| -4% | -$223K | 1.24% | 26 |
|
|
2020
Q1 | $4.32M | Buy |
+439,532
| New | +$4.32M | 0.6% | 30 |
|
|
2019
Q4 | – | Sell |
-92,215
| Closed | -$1.44M | – | 100 |
|
|
2019
Q3 | $1.44M | Hold |
92,215
| – | – | 0.17% | 67 |
|
|
2019
Q2 | $2.07M | Hold |
92,215
| – | – | 0.23% | 53 |
|
|
2019
Q1 | $6.31M | Hold |
92,215
| – | – | 0.84% | 28 |
|
|
2018
Q4 | $4.87M | Buy |
92,215
+80,034
| +657% | +$4.23M | 0.65% | 32 |
|
|
2018
Q3 | $828K | Buy |
+12,181
| New | +$828K | 0.05% | 32 |
|